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Redox signalingis C virus (HCV) are characterized by endoplasmic reticulum stress, deregulation
of the calcium homeostasis and unbalance of the oxido-reduction state. In this context, mitochondrial
dysfunction proved to be involved and is thought to contribute to the outcome of the HCV-related disease.
Here, we propose a temporal sequence of events in the HCV-infected cell whereby the primary alteration
consists of a release of Ca2+ from the endoplasmic reticulum, followed by uptake into mitochondria. This
causes successive mitochondrial alterations comprising generation of reactive oxygen and nitrogen species
and impairment of the oxidative phosphorylation. A progressive adaptive response results in an
enhancement of the glycolytic metabolism sustained by up-regulation of the hypoxia inducible factor.
Pathogenetic implications of the model are discussed.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionInfection by the hepatitis C virus (HCV) is a major cause of chronic
liver disease [1]. Worldwide about 170 million people are chronically
HCV-infected and are at risk of developing cirrhosis and hepatocel-
lular carcinoma (HCC). HCV is a positive-strand RNA virus with a 9.6-
kb genome, composed of 5′ and 3′ nontranslated regions ﬂanking an
open reading frame (ORF) encoding a large polyprotein, which is
translated on the endoplasmic reticulum (ER) and converted by viral
and host proteases into ten individual membrane-associated viral
proteins [2]. The structural proteins (core, E1 and E2 build up the virus
particle whereas the p7 polypeptide and the nonstructural proteins
(NS2–NS5B) are required for virion assembly and RNA replication [2].
Evidence indicates that HCV infection causes ER stress and the
related unfolded protein response (UPR) [3] as well as Ca2+ home-
ostasis deregulation [4,5]. In addition, alterations of mitochondria
with inhibition of the respiratory chain (RC) and generation of
reactive oxygen species (ROS) have been reported to be elicited by
HCV protein expression [5–7]. In this contribution, we will combine
the recent literature with evidence provided by our group to put
forward a mechanistic pathogenetic model.
2. Interaction of HCV proteins with mitochondria
A mounting number of diseases are reported to be linked directly
or indirectly to dysfunctioning mitochondria [8]. This is not surprising
given the central role that mitochondria play not only in the cell+39 0881 714745.
ll rights reserved.bioenergetics [9] but also in controlling signaling networks involved in
cell fate decision [10] and innate immune response [11]. The attention
that basic and clinical investigators direct to mitochondria is prompted
by thehope toﬁndnovel therapeutic targets. Chronic hepatitis Cdoesnot
escape this trend. Indeed, since the earlier ﬁndings of altered
morphology of hepatic mitochondria in patients with chronic hepatitis
C [12], a growing number of studies have been focusing on the involve-
ment of mitochondria in the pathogenesis of HCV-related liver disease.
Although the synthesis and maturation of HCV proteins occur at
the level of the ER [2], a number of studies unveiled partial localization
of some HCV proteins, notably core and NS3/4A, to the outer
mitochondrial membrane (OMM) [13–19]. In particular, HCV proteins
appear to accumulate at points of contact between mitochondria and
the ER (also designated as mitochondria-associated membranes,
MAMs). This led to the proposal that HCV proteins migrate to
mitochondria by lateral diffusion from the ER via transient fusion of
the membraneous sub-compartments [14]. Therefore, the conviction
of a direct interaction of certain HCV proteins with mitochondrial
membrane constituents has been progressively emerging though the
mechanism of interaction remains yet elusive.
Mitochondria form a dynamic reticulum intertwined with the ER.
High-resolution imaging studies proved that the two membranous
sub-cellular compartments physically contact each other in many
points [20]. These contact sites are not simply a consequence of
contiguity but constitute specialized functional areas. Molecular
determinants of these contact sites are beginning to be disclosed
[21]. A major role of these intracellular “synapses”would be to control
the Ca2+ ﬂux between the two organelles [20]. Mitochondria behave
as a high-capacity, low-afﬁnity transient calcium store. The inward
current is mainly dependent on the mitochondrial transmembrane
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contact site provides a microdomainwhere the concentration of Ca2+,
released by the opening of the ER Ca2+ channel(s), can reach localized
high concentrations, thereby enabling the functioning of the mito-
chondrial uniporter [20]. By this way, the ER may communicate with
mitochondria via Ca2+ signaling without raising the bulk cytosolic
Ca2+ level over a physiological threshold.
3. Mitochondrial and ER dysfunction caused by HCV infection
As stated above, HCV infection has been associated with enhanced
oxidative stress as well as with alteration of Ca2+ homeostasis
although their inter-play has scarcely been elucidated. A number of in
vitro studies reported that overexpression of speciﬁc HCV proteins
(mainly the core protein) resulted in enhanced production of ROS
accompanying other mitochondrial dysfunctions [4,7,23]. Similar
results were obtained in cells bearing HCV replicons or infected
with cell culture-derived HCV as well as in liver mitochondria derived
from HCV transgenic mice [7,24,25]. Some of the effects observed
could be recapitulated by incubation of puriﬁed recombinant HCV
proteins with isolated mitochondria [26,27].
Recently, we investigated the impact of the HCV protein expression
on the mitochondrial bioenergetics using a well-characterized
inducible cell model system [5,28]. U2-OS human osteosarcoma cellsFig. 1. HCV protein-related mitochondrial dysfunction is linked to Ca2+ efﬂux from the ER. U
control of a tetracycline-regulated gene expression system [5, 28]. Induction was performe
scanning confocal microscopy analysis (LSCM) of intramitochondrial Ca2+, hydrogen peroxid
imaging of the speciﬁc probes-linked ﬂuorescence, representative of three different experim
intensity signal. Digitized images were processed by ImageJ, 10 different ﬁelds were random
each cell (each ﬁeld containing 15–20 cells). The values are means±SEM; ⁎, Pb0.001 vs.
paired experimental settings. (B) Effect of dantrolene on the mitochondrial RC complex I. Me
on cell lysates as in [5]. The values are means±SEM of 3 different experiments for each exp
induced cells.were engineered to inducibly express the entire HCV ORF under the
control of a tetracycline-regulated gene expression system. Although
not supporting genuine HCV replication, these cells represent a
reliable system to study the effect of the viral proteins in the temporal
window preceding the replicative phase of the HCV life cycle. By
means of this cell model, we provided evidence that the concerted
expression of HCV proteins causes enhanced mitochondrial entry of
Ca2+ [5]. This event anticipated all the othermitochondrial alterations
comprising inhibition of the RC complex I, decrease of the mtΔΨ and
of the oxidative phosphorylation (OXPHOS) efﬁciency, generation of
ROS (O2
U− and H2O2) and reactive nitrogen species (RNS) [5]. All these
events were sensitive to treatment with speciﬁc inhibitors of the
mitochondrial Ca2+ uniporter (ruthenium red or RU360). Thus, we
concluded that the primary event triggering successive HCV-related
cell alterations is an enhanced load of Ca2+ into mitochondria.
To prove the contribution of the ER as calcium sourcewe tested the
effect of the speciﬁc inhibitor of the ER calcium channel(s) dantrolene
[29] on the mitochondrial alterations elicited by HCV protein
expression in U2-OS. Fig. 1 clearly shows that treatment of induced
cells with dantrolene completely prevented (i) mitochondrial Ca2+
overload, (ii) ROS production, (iii) dissipation of mtΔΨ, and (iv)
inhibition of RC complex I.
In order to deﬁne if a speciﬁc HCV protein was responsible for the
observedmitochondrial alterationswe extended the analysis to U2-OS2-OS cells were engineered to inducibly express the entire HCV polyprotein under the
d for 48 h. When indicated 10 μM of dantrolene was present in the media. (A) Laser
e, mtΔΨmonitored by the ﬂuorescence probes rhod1, DCF, TMRE respectively. Left side:
ents yielding comparable results. Right side: quantitative analysis of the ﬂuorescence
ly selected for each condition and the pixel intensity measured within the outline of
all the other conditions. No signiﬁcant difference was measured among all the other
asurement of the NADH dehydrogenase activity was performed spectrophotometrically
erimental setting; ⁎, Pb0.0005 vs. all the other conditions. OFF, non-induced cells; ON,
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either the HCV structural or the nonstructural proteins alone (Fig. 2).
It is shown that the expression of both structural and nonstructural
HCV proteins elicited comparable effects, i.e., enhanced mitochondrial
Ca2+ load and H2O2 generation and dissipation of mtΔΨ. All these
alterations were reversed by treatment with ruthenium red. More-
over, both structural and nonstructural HCV proteins caused a similar
substantial inhibition of RC complex I activity also sensitive to
ruthenium red treatment. It is worth noting that ruthenium red was
efﬁcient even after the full establishment of HCV protein-related
alterations. Thus, its actionwas not simply preventing but rescuing (at
least in our experimental setting).
Two possible explanations can be offered to interpret the results
above. One would rule out the role of a single speciﬁc protein in HCV-
induced mitochondrial dysfunction in favor of a more general effect
linked to overexpression of proteins and their ER-localized translation.
Overloading of protein at the ER membrane proved to cause the UPR,
which is an adaptive reaction to optimize folding and post-transla-
tional redox modiﬁcations of translated products [30]. The UPR is
mediated by ER calcium depletion. Consistently HCV-related ER stressFig. 2.HCV-linkedmitochondrial dysfunction is not elicited by a single speciﬁc HCV protein. U
as the p7 polypeptide (left panel) or the nonstructural proteins 3–5B (right panel) (D. Mor
intramitochondrial Ca2+, hydrogen peroxide, mtDY monitored by the ﬂuorescence probes rh
last 12 h of induction) is also shown. OFF, non-induced cells; ON, induced cells. The ima
preparations for each condition giving comparable results. (B) Effect of structural and nonst
enzymatic assay was carried out spectrophotometrically on cell lysates as in [5] and the valu
red treatment on non-induced and induced cells is also shown. Average of 3–4 different assand Ca2+ release activating signaling pathways have been reported
[3,31–33]. An alternative explanation is that one structural and one
nonstructural HCV protein might exert a similar redundant effect
being sufﬁcient to cause Ca2+-linked mitochondrial dysfunction even
when expressed separately.
To exclude that the observed HCV-linked mitochondrial dysfunc-
tion was not limited to a speciﬁc in vitro cell system, we have recently
extended our analyses to Huh-7.5 (human hepatocellular carcinoma)
cells transfected with an HCV genome able to sustain the complete
viral life cycle in tissue culture [34,35]. The insertion of the a GFP-
coding gene in frame within the C-terminus of HCV NS5A allowed to
track infected Huh-7.5 cell lines [36]. Using this cell model, we tested
the level of the mtΔΨ production in HCV-infected cells. Fig. 3 clearly
shows that only infected cells harboring HCV displayed a marked
decrease of the mtΔΨ. Moreover, analyses of cell subsets showed a
correlation between the level of infection (monitored by the
ﬂuorescence intensity of the NS5A-GFP fusion protein) and the
extent of the mtΔΨ. Importantly, treatment of infected Huh-7.5 cell
line with either ruthenium red or dantrolene, likewise for HCV-
induced U2-OS cells, resulted in a marked ablation of both the mtΔΨ2-OS cells were engineered to inducibly express either the HCV structural region as well
adpour, unpublished data). HCV proteins were induced for 48 h. (A) LSCM analysis of
od1, DCF, TMRE respectively. The effect of 5 μM ruthenium red treatment (added in the
ges displayed in the two composite panels are representative of three different cell
ructural HCV protein expression on NADH dehydrogenase activity of RC complex I. The
es reported were corrected for the rotenone-sensitivity activity. The effect of ruthenium
ays, for each condition, ±SEM.
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tively these observations highlight that the HCV-linked mitochon-
drial dysfunction is not conﬁned to a speciﬁc cell type or to the
modalities of the viral protein expression but rather is a general
hallmark of HCV-cell host interaction.
4. HCV-related cell bioenergetic alterations
An important point to be considered concerns the biological
consequences of the HCV-induced redox unbalance in the infected
cell. Studies reported that HCV protein expression elicits either
stimulation [37–39] or inhibition [40–44] of cell death. In our in
vitro system, the inducible expression of the HCV proteins did not
result in cell distress (i.e. reduced cell viability) when the induction
was performed for 48 h [5]. However, when the induction protocol
was maintained for periods longer than 48 h a cell density-dependent
decline in cell growth rates was observed. This would indicate that the
production of ROS was kept initially below the cytotoxic level but that
a progressive chronic nitro-oxidative insult resulted in impairment of
the cell cycle and/or in cell death. This obvious conclusion may turn
out, however, to be an over-simpliﬁcation not accounting for the
potential adaptive response of the cell. Surprisingly, ATP measure-
ments showed higher concentrations in cells induced for 5 days thanFig. 3.Detection of mtΔΨ in infected HCV-replicating Huh 7.5 cells. A fully replication-compe
Huh-7.5 cells (Digital Bio Technology) [36]. (B) LSCM analysis of mtΔΨ evaluated by the TM
TMRE as in [5] and sequentially scanned to detect ﬁrst the GFP-related green ﬂuorescence an
representative of the results obtained from 20 randomly selected ﬁelds. (B) Quantitative anal
storage and analysis of data were performed with LaserSharp and LaserPix software from
intermediate and high GFP-ﬂuorescence. The overall number of cells analysed was 250 (from
population. Two-tailed Student t-test was applied to estimate the indicated P value.in non-induced cells [unpublished data]. Thus, in spite of the HCV-
linkedmitochondrial dysfunction the induced cell still preserved a full
bioenergetic competence. However, when cells were grown in a
galactose-based medium HCV induction resulted in severe impair-
ment of ATP production and pronounced cell-death [5]. Taken
together, these results indicate that when the cell metabolism is not
forced to rely exclusively on oxidative phosphorylation, HCV proteins
somehow induce an adaptive response conferring pro-survival to the
infected cells.
To further explore the basis for this observation, we investigated
whether there was an up-regulation of the glycolytic pathway. Indeed
a three-fold increase of lactate release in the culture medium was
measured in HCV-induced U2-OS cells [unpublished data]. All the
glycolytic enzymes as well as the glucose transporter(s) are under
transcriptional control of the hypoxia induced factor (HIF) [45,46].
Activation of HIF depends on the hypoxia-dependent stabilization of
subunit HIF-1α, which under normoxic conditions is rapidly proteo-
lysed following O2-dependent post-translational modiﬁcation [47].
However factors in addition to hypoxia have been described to
stabilize HIF-1α [48].
Interestingly a recent study reported that HCV-infected Huh-7 cells
stabilize HIF-1α under normal oxygen tension [49]. Moreover, the
HCV-related HIF-1α stabilization was sensitive to treatment of thetent HCV genome harbouring a GFP insertion in NS5A (A) wasmicro-electroporated into
RE ﬂuorescent probe. The electroporated Huh-7.5 cell sample was incubated with 2 μM
d then the TMRE-related red ﬂuorescence in the same optical ﬁeld. The image shown is
ysis from single cell-measurements of the green/red ﬂuorescence intensity. Acquisition,
Biorad. The values shown are means±SEM from cells selected on the basis of null,
two different experiments) and the subsets expressed as percentage of the entire cell
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We have recently extended these observations conﬁrming an HCV-
dependent activation of HIF-1α and an up-regulation of HIF-
controlled gene expression both in cell cultures and in hepatitis C
affected patients [M. Ripoli et al., manuscript in preparation]. Of note,
in addition to providing a metabolic adaptive response to hypoxia, HIF
controls the transcription of a wide range of factors involved in
angiogenesis, cell proliferation, survival, apoptosis and many other
cell pathways [50]. Therefore, its activation has been implicated in the
onset, progression and diffusion of solid tumours [51].
5. Sequence of HCV protein-induced mitochondrial alterations
Fig. 4 illustrates a possible sequence of events following HCV
infection that combine evidence provided by our group with others
present in literature and offers amechanisticworkingmodel amenable
to further validation. It is proposed that although the bulk of HCV
proteins accumulate at the ER and ER-derived modiﬁed membranes
[2], a portion that speciﬁcally localizes to ER–mitochondria contact
sites is responsible for the observed HCV-linked mitochondrial
alterations. The priming event is the release of Ca2+ from ER stores
by opening of the Ca2+ channel(s). The mechanism is not fully
understood but a direct interaction or an ER stress-mediated indirect
effect can both be considered and are not mutually exclusive [31–33].
The activated outward ﬂux of Ca2+ from the ER enhances its local
concentration at ER–mitochondria contact siteswithout increasing the
bulk cytoplasmic Ca2+ concentration [20]. The entry of Ca2+ into
mitochondria is mediated by the voltage-dependent anion channelFig. 4. Sequence of HCV protein-induced mitochondrial alterations. An ER-mitochondria con
The different shapes reﬂect their level of integrationwith the phospholipids bilayer. These are
proteinwith both the ER- and OMM-located Ca2+ transporters elicits release of Ca2+ from th
state level ensues a cascade of events leading to dysfunction of the OXPHOS system and pr(VDAC)/porin of the OMMandby theΔΨ-driven Ca2+ uniporter of the
IMM [22,52–54]. Direct interaction of HCV proteins with the
mitochondrial transport system(s) cannot be excluded [24,25]. Inter-
membrane transfer of proteins from the ER to the OMM is shown as a
possible mechanism to account for the reported localization of HCV
proteins on mitochondria [14]. Although the viral proteins conﬁne to
the OMM, effects on IMM constituents might take place via inter-
membrane protein–protein interaction likely occurring at the OMM–
IMM contact sites. Core, NS3/4A and NS5A might be possible speciﬁc
candidates in case of a direct interaction with mitochondrial
components [14,18,19,24–27]. The main mitochondrial exit route of
Ca2+ ismediated by theNa+/Ca2+exchanger andby transient opening
(ﬂickering) of the mitochondrial permeability transition pore (MPTP).
[22,53]. Re-uptake of Ca2+ by the ER is dependent on the Ca2+ ATPase.
Enhanced recycling of Ca2+ is expected to decrease the mtΔΨ and
thereby the efﬁciency of ATP synthesis [22,53]. However, this effect is
compensated by the Ca2+-mediated activation of the Krebs' cycle
dehydrogenases, which enhancing the reducing substrate availability
for the RC, up-regulates the OXPHOS whereby leading to a prompt
adaptive response to the energy-requiring stressing condition [54].
This mechanism may be beneﬁcial, if time controlled, to overcome
transient bioenergetic impairment but becomes harmful when the
insult persists for extended periods as in the case of the chronic viral
infection [54]. High levels of mitochondrial Ca2+may cause changes in
the redox balance by a number of described mechanisms that are not
mutually exclusive. Consistent with our observations it is worth-
mentioning that mitochondrial Ca2+ overload was shown to displace
cytochrome c from the IMM-cardiolipin slowing down the ﬂux oftact site is schematically drawn. HCV proteins are shown in purple on the ER and OMM.
supposed to transfer by lateral diffusion from ER to the OMM. Direct interaction of HCV
e ER and/or uptake of Ca2+ within the mitochondria. Herein the enhanced Ca2+ steady-
ogressive change in the redox state. See text for description of the model.
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oxidase [53,55]. In addition, Ca2+ activates the mitochondrial isoform
of a nitric oxide synthase, thereby releasing NOU, which is an inhibitor
of cytochrome c oxidase [56]. The synergistic combination of these
two events are expected to cause accumulation of reducing equiva-
lents upstream of cytochrome c oxidase, resulting in electron leakage
to O2 with formation of O2
U− over the basal level [57]. Moreover, NO
and Ca2+ can directly inhibit the RC complex I, enhancing ROS
production by this complex [58,59]. In order to counterbalance this
increase of ROS production the intramitochondrial redox buffer
(mainly GSH) becomes progressively depleted. Re-reduction of
GSSG by glutathione reductase requires NADPH, which is largely
provided by the mitochondrial NADH/NADPH trans-hydrogenase
activity [60]. However, this is an IMM enzyme catalyzing a ΔΨ-driven
reduction of NADP+. Thus, it is tempting to speculate that the reduced
mtΔΨ observed in mitochondria of HCV-infected cells would limit the
trans-hydrogenase activity, leading in turn to accumulation of
oxidised glutathione (GSSG). GSSG can form mixed disulphide
bonds with protein cysteine thiols and the RC complex I was shown
to be susceptible to reversible glutathionylation, which causes partial
inhibition of its activity and enhanced generation of O2
U− [61].
Moreover, ROS has been shown to affect the ER Ca2+ channels [53].
These last processes would therefore fuel a positive feedback
mechanism. Their occurrence in cell models of HCV-infectionFig. 5. Proposed pathogenic role of mitochondria in the development of HCV-related diseases
adaptive bioenergetic response of the cell is ensued. In this context the pathological outcome
Low ROS level re-enforces a pro-survival and proliferative phenotype by redox signalling.
expansion leading to hepatocarcinoma. ii) Intermediate levels of ROS and Ca2+ enhances
metabolites needed to import and catabolize long chain acyl-CoA by β-oxidation thereby lea
to steatosis. iii) High intramitochondrial concentrations of Ca2+ and ROS induces permanent
release of cytochrome c and other pro-apoptotic factors triggers the caspase-cascade. Depen
the last case, tissue ﬁbrosis. See text for further explanation.warrants further investigation and in this respect experimental
work is in progress in our lab.
6. A pathogenic model for HCV-related liver diseases
A major point to be discussed concerns the biological effects, in
terms of cell fate, that the oxidative unbalance causes in HCV infected
cells. This issue has to be considered taking in account the strategy of
interaction between the virus and the infected host cell. On the one
hand, if the infected cell is not able to clear HCV infection by immune
or other (e.g., autophagy) protective mechanisms it might be
convenient to provoke cell death in order to limit virus dissemination
in the organism. On the other hand, from the viewpoint of the virus it
is convenient to interfere with the auto-disruption of the host cell to
fully exploit it as energy and matter source needed to nourish
replication and virus assembly. Some viruses, in the late stage of
their life cycle, favour the death of the host cell to promote
dissemination of the infection. However, this does not apply to HCV,
which is non-cytolytic.
In the scheme shown in Fig. 5 a pathogenic model is presented
whereby the level of the redox unbalance is proposed to modulate the
variable pathological outcomes of the HCV infection. Indeed, depend-
ing on compartmentalization, amount, frequency of production, and
speciﬁc chemical species, ROS proved to result in signaling for a broad. Consequently to the HCV-induced dysfunction of themitochondrial OXPHOS system an
s of the HCV infection are suggested to depend on the level of the oxidative alteration. i)
If additional hits (mutagenic) accumulate over the time this may result in clonogenic
the closed to open transition of the MPTP causing depletion of low-molecular weight
ding to their cytoplasmic accumulation and conversion in triglycerides. This would lead
opening of the MPTP causing osmotic swelling and rupture of the OMM. The consequent
ding on the intracellular ATP level, this would lead to apoptosis or necrosis activating, in
545C. Piccoli et al. / Biochimica et Biophysica Acta 1787 (2009) 539–546array of biological effects from cell survival to suicide [62–64].
Intriguingly, contradictory evidence has been reported concerning
the effect of HCV protein expression on cell growth [37–44].
It is proposed that low production of ROS is not harmful to the cell
but instead promotes pro-survival adaptation of HCV infected cells via
redox signalling-mediated mechanism [62,63]. This might be further
favoured by described HCV-related activation of antiapoptotic path-
ways (i.e. HIF, NF-kB, JNK, STAT3) [26,49]. However, the proliferative
advantage of HCV-infected cells under low ROS generation regime can
lead to accumulation of mutagenic hits resulting in carcinogenic
priming of the host cell and ultimately in HCC development [51,64].
At intermediate level of oxidative insult (and Ca2+ deregulation) a
possible link between mitochondrial dysfunction and altered lipid
metabolism (hallmarking HCV infection [65]) may establish. HCV-
linked cirrhotic progression relies, at the cell biochemical level, on
increased triglyceride synthesis, which likely occurs because of
defective free fatty acid (FFA) oxidation. Utilization of FFA takes
place mainly within the mitochondrial matrix by mean of the β-
oxidation pathway. The entry of activated long-chain FFA as acyl-CoA
into mitochondria requires conversion to acyl-carnitine by the
carnitine acyl-CoA transferase (CAT1-isoform) which is located in
the mitochondrial inter-membrane space [66]. A carnitine/acyl-
carnitine translocase allows acyl-carnitine to enter the mitochondria
in exchange with carnitine. The compartmentalization of this process
allows prompt replenishing of free carnitine in the inter-membrane
space. As opening of the MPTP allows rapid equilibration of solutes of
molecular weight up to 1500 Da [67,68] it is conceivable to
hypothesize that enhanced ﬂickering of the MPTP might cause low
molecular weight molecules like carnitine (or CoA (M.W. 162 and
767 Da respectively)) to diffuse and dilute in the cytoplasm. This
would cause a loss of the micro-environmental control of the
conversion of acyl-CoA into acyl-carnitine. Thus, accumulating acyl-
CoA molecules are forced toward triglyceride synthesis, with pro-
gressive formation of lipid droplets leading to steatosis in HCV-
infected hepatocytes. Deregulation of metabolism-controlling master
transcription factors, like the peroxisome proliferators activating
receptor alpha (PPAR-α) [69], would further exacerbate the lipogenic
process.
High concentrations of mitochondrial Ca2+, ROS (O2
U−, H2O2) and
RNS (NOU, ONOO−) are all powerful triggers of the mitochondrial
MPTP permanent opening [70]. The resulting osmotic swelling
(caused by the large intramitochondrial oncotic pressure) causes
rupture of the OMM and release of cytochrome c and other pro-
apoptotic factors, which initiates a practically irreversible step in the
apoptotic program [10]. However, depending on the intracellular ATP
level the apoptotic program can diverge toward necrotic cell death
[71]. Thus, high ROS production regimes may overwhelm the pro-
survival setting resulting in HCV-related inﬂamatory ﬁbrogenesis.
The different pathogenic outcomes related to the variable level of
the HCV-linked oxidative insult may depend on differences in the
cellular virus load or viral protein expression and/or on age-
dependent factors of the host.
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